Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Is total duration of distal compound muscle action potential better than negative peak duration in the diagnosis of chronic inflammatory demyelinating polyneuropathy?
Bradykinin type 2 receptor -9/-9 genotype is associated with triceps brachii muscle hypertrophy following strength training in young healthy men.
P2X Receptors as Drug Targets.
Muscle oxygen consumption by NIRS and mobility in multiple sclerosis patients.
MicroRNA let-7e is associated with the pathogenesis of experimental autoimmune encephalomyelitis.
Clinical association of intrathecal and mirrored oligoclonal bands in paediatric neurology.
[Differential diagnosis of optic neuritis (review].
Recent advances in understanding the molecular mechanisms of the development and function of Th17 cells.
Expression and Genetic Analysis of MicroRNAs Involved in Multiple Sclerosis.
Atypical idiopathic inflammatory demyelinating lesions: prognostic implications and relation to multiple sclerosis.
Current and emerging therapies for multiple sclerosis.
Neurological and psychiatric disorders as a neuroglial failure.
Apcdd1 stimulates oligodendrocyte differentiation after white matter injury.
Longitudinally extensive transverse myelitis as presenting manifestation of small cell carcinoma lung.
Protein-based classifier to predict conversion from clinically isolated syndrome to multiple sclerosis.
Acrolein-mediated conduction loss is partially restored by potassium channel blockers.
Therapeutic Advances and Future Prospects in Progressive Forms of Multiple Sclerosis.
Genome and transcriptome of the porcine whipworm Trichuris suis.
Cost-effectiveness of an adjustment group for people with multiple sclerosis and low mood: a randomized trial.
Suppression of experimental autoimmune encephalomyelitis by interleukin-10 transduced neural stem/progenitor cells.
Re. 'Doppler Ultrasound Examination of Multiple Sclerosis Patients and Control Participants: Inter-observer Agreement and Association with Disease'
Factors affecting bone mineral density in multiple sclerosis patients.
A prospective study of "undiagnosed" isolated myelopathy: II. Value of magnetic resonance imaging, evoked potentials and CSF analysis.
Pathophysiology, assessment and management of multiple sclerosis spasticity: an update.
1H-Magnetic Resonance Spectroscopy in diffuse and focal cervical cord lesions in Multiple Sclerosis.
Pages
« first
‹ previous
…
542
543
544
545
546
547
548
549
550
…
next ›
last »